GlobalData, the industry analysis specialist, has released its new report, “Atopic Dermatitis Therapeutics – Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of information and analysis on the global Atopic Dermatitis Therapeutics market. The report identifies the key trends shaping and driving the global Atopic Dermatitis Therapeutics market.

1. Atopic Dermatitis Therapeutics – Pipeline Assessment and Market Forecasts to
2018
ReportsnReports.com adds GlobalData Market Research Report “Atopic Dermatitis
Therapeutics – Pipeline Assessment and Market Forecasts to 2018’’ to its store.
GlobalData, the industry analysis specialist, has released its new report, “Atopic Dermatitis
Therapeutics – Pipeline Assessment and Market Forecasts to 2018”. The report is an
essential source of information and analysis on the global Atopic Dermatitis Therapeutics
market. The report identifies the key trends shaping and driving the global Atopic Dermatitis
Therapeutics market.
The report also provides insights on the prevalent competitive landscape and the emerging
players expected to significantly alter the market positioning of the current market leaders.
Most importantly, the report provides valuable insights on the pipeline products within the
global Atopic Dermatitis Therapeutics sector. This report is built using data and information
sourced from proprietary databases, primary and secondary research and in-house analysis
by GlobalData’s team of industry experts.
Scope
The report provides information on the key drivers and challenges of the Atopic Dermatitis
Therapeutics market. Its scope includes -
 Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Atopic
Dermatitis Therapeutics market revenues data from 2005 to 2009, forecast for eight
years to 2017.
 Pipeline analysis data providing a split across the different phases, mechanisms of action
being developed and emerging trends by seven key markets. Pipeline candidates fall
under major therapeutic classes.
 Analysis of the current and future competition in the seven key countries Atopic
Dermatitis Therapeutics market.
 Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
 Key topics covered include strategic competitor assessment, market characterization,
unmet needs and the implications for the Atopic Dermatitis Therapeutics market.
 Analysis of key recent licensing and partnership agreements in Atopic Dermatitis
Therapeutics market
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
 Develop and design your in-licensing and out-licensing strategies through a review of
pipeline products and technologies and by identifying the companies with the most
robust pipeline.
 Develop business strategies by understanding the trends shaping and driving the global
Atopic Dermatitis Therapeutics market.

2.  Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Atopic Dermatitis
Therapeutics market in future.
 Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
 Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
 Organize your sales and marketing efforts by identifying the market categories and
segments that present maximum opportunities for consolidations, investments and
strategic partnerships.
 What’s the next big thing in the global Atopic Dermatitis Therapeutics market landscape?
– Identify, understand and capitalize.
Table of contents
1 Table of contents
1.1 List of Tables
1.2 List of Figures
2 Atopic Dermatitis – Introduction
2.1 Overview
2.2 Epidemiology
2.3 Etiology
2.4 Symptoms
2.5 Diagnosis
2.6 Pathophysiology
2.7 Treatment and Management Pattern
2.8 GlobalData Pipeline Report Guidance
3 Atopic DermatitisTherapeutics – Market Characterization
3.1 Atopic Dermatitis Market Size (2005 – 2010) – Global
3.2 Atopic Dermatitis Market Forecast (2010 – 2018) – Global
3.3 Atopic Dermatitis Market Size (2005 – 2010) – The US
3.4 Atopic Dermatitis Market Forecast (2010 – 2018) – The US
3.5 Atopic Dermatitis Market Size (2005 – 2010) – France
3.6 Atopic Dermatitis Market Forecast (2010 – 2018) – France
3.7 Atopic Dermatitis Market Size (2005 – 2010) – Germany
3.8 Atopic Dermatitis Market Forecast (2010 – 2018) – Germany
3.9 Atopic Dermatitis Market Size (2005 – 2010) – Italy
3.10 Atopic Dermatitis Market Forecast (2010 – 2018) – Italy
3.11 Atopic Dermatitis Market Size (2005 – 2010) – Spain
3.12 Atopic Dermatitis Market Forecast (2010 – 2018) – Spain
3.13 Atopic Dermatitis Market Size (2005 – 2010) – The UK
3.14 Atopic Dermatitis Market Forecast (2010 – 2018) – The UK
3.15 Atopic Dermatitis Market Size (2005 – 2010) – Japan
3.16 Atopic Dermatitis Market Forecast (2010 – 2018) – Japan
3.17 Drivers and Barriers for the Atopic Dermatitis Market
3.17.1 Drivers for the Atopic Dermatitis Market
3.17.2 Barriers for the Atopic Dermatitis Market

3. 3.18 Opportunity and Unmet Need
3.19 Key Takeaway
4 Atopic Dermatitis Market – Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profile for Major Marketed Products in the Atopic Dermatitis Market
4.3.1 Protopic (tacrolimus)
4.3.2 Elidel (pimecrolimus)
4.3.3 MimyX
4.3.4 Atopiclair
4.3.5 Topical Corticosteroids
4.4 Key Takeaway
5 Atopic Dermatitis – Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Atopic Dermatitis – Pipeline Analysis by Phase of Development
5.3.1 Atopic Dermatitis – Filed and Phase III Pipeline
5.3.2 Atopic Dermatitis – Phase II Pipeline
5.3.3 Atopic Dermatitis – Phase I Pipeline
5.3.4 Atopic Dermatitis – Preclinical Pipeline
5.4 Atopic Dermatitis – Pipeline by Mechanism of Action
5.5 Technology Trends Analytical Framework
5.6 Most Promising Drug Profiles
5.6.1 LAS 41002
5.7 Key Takeaway
6 Atopic Dermatitis – Clinical Trials Mapping
6.1 Clinical Trials by Region and Country
6.2 Clinical Trials by Phase of Clinical Development
6.3 Clinical Trials by Trial Status
6.4 Clinical Trials by Sponsors
6.5 Top Companies Participating in Atopic Dermatitis Clinical Trials
7 Atopic Dermatitis Market – Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Future Market Competition Scenario
8 Atopic Dermatitis Market – Future Companies
8.1 Introduction
8.2 Company Profiles
8.2.1 Almirall
8.2.2 Anacor Pharmaceuticals
8.2.3 BioCis Pharmaceuticals
8.2.4 MIKA Pharma GmbH
8.3 Details of Other Companies in the Pipeline
8.4 Key Takeaway

4. 9 Atopic Dermatitis – Licensing and Partnership Deals
10 Atopic Dermatitis – Appendix
10.1 Definitions
10.2 Acronyms
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography
List of Tables
Table 1: Atopic Dermatitis Therapeutics – Treatment Options
Table 2: Atopic Dermatitis Therapeutics – Commonly Used Topical Corticosteroids
Table 3: Atopic Dermatitis Market, Global, Revenue ($m), 2005 – 2010
Table 4: Atopic Dermatitis Market, Global, Forecast ($m), 2010 – 2018
Table 5: Atopic Dermatitis Therapeutics Market, The US, Revenue ($m), 2005 – 2010
Table 6: Atopic Dermatitis Market, The US, Forecast ($m), 2010 – 2018
Table 7: Atopic Dermatitis Market, France, Revenue ($m), 2005 – 2010
Table 8: Atopic Dermatitis Market, France, Forecast ($m), 2010 – 2018
Table 9: Atopic Dermatitis Market, Germany, Revenue ($m), 2005 – 2010
Table 10: Atopic Dermatitis Market, Germany, Forecast ($m), 2010 – 2018
Table 11: Atopic Dermatitis Market, Italy, Revenue ($m), 2005 – 2010
Table 12: Atopic Dermatitis Market, Italy, Forecast ($m), 2010 – 2018
Table 13: Atopic Dermatitis Market, Spain, Revenue ($m), 2005 – 2010
Table 14: Atopic Dermatitis Market, Spain, Forecast ($m), 2010 – 2018
Table 15: Atopic Dermatitis Market, The UK, Revenue ($m), 2005 – 2010
Table 16: Atopic Dermatitis Market, The UK, Forecast ($m), 2010 – 2018
Table 17: Atopic Dermatitis Market, Japan, Revenue ($m), 2005 – 2010
Table 18: Atopic Dermatitis Market, Japan, Forecast ($m), 2010 – 2018
Table 19: Atopic Dermatitis Therapeutics Market, Global, Comparative Study on the Efficacy
of Protopic in Phase III Clinical Trials, 2003
Table 20: Atopic Dermatitis Therapeutics Market, Global, Comparative Study on the Efficacy
of Elidel in Clinical Trials, 1998 – 2002
Table 21: Atopic Dermatitis Therapeutics Market, Global, Major Marketed Products
Comparison, 2011
Table 22: Atopic Dermatitis Therapeutics – Phase III Clinical Pipeline, 2011
Table 23: Atopic Dermatitis Therapeutics – Phase II Clinical Pipeline, 2011
Table 24: Atopic Dermatitis Therapeutics – Phase I Clinical Pipeline, 2011
Table 25: Atopic Dermatitis Therapeutics – Pre-Clinical and Discovery Pipeline, 2011
Table 26: LAS 41002 – Clinical Study Details
Table 27: Atopic Dermatitis, Global, Clinical Trials, 2011
Table 28: Atopic Dermatitis, Global, Clinical Trials by Phase, 2011
Table 29: Atopic Dermatitis, Global, Clinical Trials by Status of Development, 2011
Table 30: Atopic Dermatitis, Global, Overall Sponsors, 2011

5. Table 31: Atopic Dermatitis, Global, Prominent Sponsors, 2011
Table 32: Atopic Dermatitis, Global, Top Ten Companies by Phase, 2011
Table 33: Almirall – Dermatology Pipeline Products, 2011
Table 34: Anacor Pharmaceuticals – Dermatology Pipeline Products, 2011
Table 35: BioCis Pharmaceuticals – Dermatology Pipeline Products, 2011
Table 36: MIKA Pharma GmbH – Dermatology Pipeline Products, 2011
Table 37: Description of Other Companies in the Pipeline, 2011
Table 38: Atopic Dermatitis, Global, Deals, 2011
List of Figures
Figure 1: Atopic Dermatitis Therapeutics – Eczematous Skin
Figure 2: Atopic Dermatitis – Causes of Atopic Dermatitis
Figure 3: Atopic Dermatitis – Sign and Symptoms
Figure 4: Atopic Dermatitis – Pathophysiology
Figure 5: Atopic Dermatitis – Treatment Algorithm
Figure 6: Atopic Dermatitis Therapeutics Market, Global, Revenue ($m), 2005 – 2010
Figure 7: Atopic Dermatitis Therapeutics Market, Global, Forecast ($m), 2010 – 2018
Figure 8: Atopic Dermatitis Therapeutics Market, The US, Revenue ($m), 2005 – 2010
Figure 9: Atopic Dermatitis Therapeutics Market, The US, Forecast ($m), 2010 – 2018
Figure 10: Atopic Dermatitis Therapeutics Market, France, Revenue ($m), 2005 – 2010
Figure 11: Atopic Dermatitis Therapeutics Market, France, Forecast ($m), 2010 – 2018
Figure 12: Atopic Dermatitis Therapeutics Market, Germany , Revenue ($m), 2005 – 2010
Figure 13: Atopic Dermatitis Therapeutics Market, Germany, Forecast ($m), 2010 – 2018
Figure 14: Atopic Dermatitis Therapeutics Market, Italy, Revenue ($m), 2005 – 2010
Figure 15: Atopic Dermatitis Therapeutics Market, Italy, Forecast ($m), 2010 – 2018
Figure 16: Atopic Dermatitis Therapeutics Market, Spain, Revenue ($m), 2005 – 2010
Figure 17: Atopic Dermatitis Therapeutics Market, Spain, Forecast ($m), 2010 – 2018
Figure 18: Atopic Dermatitis Therapeutics Market, The UK, Revenue ($m), 2005 – 2010
Figure 19: Atopic Dermatitis Therapeutics Market, The UK, Forecast ($m), 2010 – 2018
Figure 20: Atopic Dermatitis Therapeutics Market, Japan, Revenue ($m), 2005 – 2010
Figure 21: Atopic Dermatitis Therapeutics Market, Japan, Forecast ($m), 2010 – 2018
Figure 22: Opportunity and Unmet Need in the Atopic Dermatitis Therapeutics Market, 2011
Figure 23: Strategic Competitor Assessment of the Marketed Products in Atopic Dermatitis
Therapeutics, 2011
Figure 24: Atopic Dermatitis Therapeutics, Clinical Pipeline by Mechanism of Action (%),
2011
Figure 25: Atopic Dermatitis – Clinical Pipeline by Phase of Development (%), 2011
Figure 26: Technology Trends Analytics Framework, 2011
Figure 27: Technology Trends Analytics Framework – Description, 2011
Figure 28: Atopic Dermatitis, Global, Clinical Trials by Country, 2011
Figure 29: Atopic Dermatitis, Global, Clinical Trials by Phase (%), 2011
Figure 30: Atopic Dermatitis, Global, Clinical Trials by Status of Development (%), 2011
Figure 31: Atopic Dermatitis, Global, Overall Sponsors (%), 2011
Figure 32: Atopic Dermatitis, Global, Prominent Sponsors (%), 2011
Figure 33: Atopic Dermatitis, Global, Top Companies by Phase, 2011
Figure 34: Atopic Dermatitis Market, Drivers and Barriers, 2011
Figure 35: Implications for Future Market Competition in the Atopic Dermatitis Therapeutics
Market, 2011

6. Figure 36: Atopic Dermatitis Market, Clinical Pipeline by Company, 2011
Figure 37: GlobalData Market Forecasting Model
Latest Market Research Reports:
 Rheumatoid Arthritis Therapeutics – Pipeline Assessment and Market Forecasts to 2018
 Luxembourg Power Market Outlook to 2030 – Business Propensity Indicator ( BPI )
Market Trends Regulation and Competitive Landscape
 Cell Culture: The World Market for Media, Sera and Reagents, 3rd. Edition
 Fats and Salad/Cooking Oils in the U.S.: Butter, Margarine, Olive Oil, and Beyond Cell
Culture: The World Market for Media, Sera and Reagents, 3rd. Edition
About Us:
ReportsnReports is an online library of over 75,000 market research reports and in-depth
market research studies & analysis of over 5000 micro markets. We provide 24/7 online and
offline support to our customers. Get in touch with us for your needs of market research
reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr. Priyank
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit Our Blog: Market Research Reports